Travere Therapeutics Financial Overview
Travere Therapeutics's market cap is currently $3.60B. The company's EPS TTM is $0.28; its P/E ratio is -37.14; Travere Therapeutics is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
